Kofeina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kofeina" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
1st place
1st place
5th place
2nd place
3,887th place
1,274th place
87th place
5th place
934th place
low place
924th place
75th place
68th place
31st place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
7,545th place
7,109th place
low place
881st place
2,525th place
1,409th place
769th place
8,167th place
3rd place
27th place
301st place
151st place
4,848th place
8,888th place
low place
low place
4,592nd place
91st place
low place
984th place
low place
low place
1,610th place
4,301st place
low place
1,219th place
low place
low place
low place
low place

archeowiesci.pl

archive.is

books.google.com

  • Oudry, Note sur la Théine, „Nouvelle bibliothèque médicale, augmentée d'un recueil de médecine vétérinaire, et bulletin de l'Athénée de médicine de Paris”, 1, 1827, s. 477–479 [dostęp 2022-08-29] (fr.).

bris.ac.uk

chm.bris.ac.uk

coca-colacompany.com

coffeefaq.com

cspinet.org

doi.org

dx.doi.org

  • Peter M. Frischknecht, Jindra Ulmer-Dufek, Thomas W. Baumann, Purine alkaloid formation in buds and developing leaflets of Coffea arabica: Expression of an optimal defence strategy?, „Phytochemistry”, 25 (3), 1986, s. 613–616, DOI10.1016/0031-9422(86)88009-8 [dostęp 2022-08-29] (ang.).
  • Thomas W. Baumann, Helene Gabriel, Metabolism and Excretion of Caffeine during Germination of Coffea arabica L., „Plant and Cell Physiology”, 25 (8), 1984, s. 1431–1436, DOI10.1093/oxfordjournals.pcp.a076854 [dostęp 2022-08-29] (ang.).
  • Reinhard Matissek, Evaluation of xanthine derivatives in chocolate - nutritional and chemical aspects, „Zeitschrift für Lebensmitteluntersuchung und -Forschung A”, 205 (3), 1997, s. 175–184, DOI10.1007/s002170050148 [dostęp 2022-08-29] (ang.).
  • D.S. Groisser, A study of caffeine in tea. I. A new spectrophotometric micro-method. II. Concentration of caffeine in various strengths, brands, blends, and types of teas, „The American Journal of Clinical Nutrition”, 31 (10), 1978, s. 1727–1731, DOI10.1093/ajcn/31.10.1727, PMID707326 [dostęp 2022-08-29] (ang.).
  • C.F. Haskell i inni, A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans, „Journal of Psychopharmacology”, 21 (1), 2007, s. 65–70, DOI10.1177/0269881106063815, PMID16533867 [dostęp 2022-08-29] (ang.).
  • Hendrik J. Smit, Elizabeth A. Gaffan, Peter J. Rogers, Methylxanthines are the psycho-pharmacologically active constituents of chocolate, „Psychopharmacology”, 176 (3-4), 2004, s. 412–419, DOI10.1007/s00213-004-1898-3, PMID15549276 [dostęp 2022-08-29] (ang.).
  • L.T. Benjamin, A.M. Rogers, A. Rosenbaum, Coca-Cola, caffeine, and mental deficiency: Harry Hollingworth and the Chattanooga trial of 1911, „Journal of the History of the Behavioral Sciences”, 27 (1), 1991, s. 42–55, DOI10.1002/1520-6696(199101)27:1<42::aid-jhbs2300270105>3.0.co;2-1, PMID2010614 [dostęp 2022-08-29] (ang.).
  • Jaime Wisniak, Pierre-Jean Robiquet, „Educación Química”, 24 (1), 2018, s. 139–149, DOI10.1016/S0187-893X(13)72507-2, ISSN 1870-8404 [dostęp 2018-10-29] (ang.).
  • G.J. Mulder, Ueber Theïn und Caffeïn, „Journal für Praktische Chemie”, 15 (1), 1838, s. 280–284, DOI10.1002/prac.18380150124 [dostęp 2022-08-29] (niem.).
  • Carl Jobst, Thein identisch mit Caffein, „Annalen der Pharmacie”, 25 (1), 1838, s. 63–66, DOI10.1002/jlac.18380250106 [dostęp 2022-08-29] (niem.).
  • Davir González-Calderón i inni, Synthesis of caffeine from theobromine: Bringing back an old experiment in a new setting, „Educación Química”, 26 (1), 2015, s. 9–12, DOI10.1016/S0187-893X(15)72092-6 [dostęp 2024-01-09] (ang.).
  • A. Nehlig, J.L. Daval, G. Debry, Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, „Brain Research. Brain Research Reviews”, 17 (2), 1992, s. 139–170, DOI10.1016/0165-0173(92)90012-b, PMID1356551 [dostęp 2022-08-29] (ang.).
  • A. Liguori, J.R. Hughes, J.A. Grass, Absorption and subjective effects of caffeine from coffee, cola and capsules, „Pharmacology, Biochemistry, and Behavior”, 58 (3), 1997, s. 721–726, DOI10.1016/s0091-3057(97)00003-8, PMID9329065 [dostęp 2022-08-29] (ang.).
  • R. Newton i inni, Plasma and salivary pharmacokinetics of caffeine in man, „European Journal of Clinical Pharmacology”, 21 (1), 1981, s. 45–52, DOI10.1007/BF00609587, PMID7333346 [dostęp 2022-08-29] (ang.).
  • J.R. Graham, Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine, „The New England Journal of Medicine”, 250 (22), 1954, s. 936–938, DOI10.1056/NEJM195406032502203, PMID13165929 [dostęp 2022-08-29] (ang.).
  • G. Fisone, A. Borgkvist, A. Usiello, Caffeine as a psychomotor stimulant: mechanism of action, „Cellular and molecular life sciences: CMLS”, 61 (7-8), 2004, s. 857–872, DOI10.1007/s00018-003-3269-3, PMID15095008 [dostęp 2022-08-29] (ang.).
  • S. Latini, F. Pedata, Adenosine in the central nervous system: release mechanisms and extracellular concentrations, „Journal of Neurochemistry”, 79 (3), 2001, s. 463–484, DOI10.1046/j.1471-4159.2001.00607.x, PMID11701750 [dostęp 2022-08-29] (ang.).
  • Radhika Basheer i inni, Adenosine and sleep-wake regulation, „Progress in Neurobiology”, 73 (6), 2004, s. 379–396, DOI10.1016/j.pneurobio.2004.06.004, PMID15313333 [dostęp 2022-08-29] (ang.).
  • Zhi-Li Huang i inni, Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine, „Nature Neuroscience”, 8 (7), 2005, s. 858–859, DOI10.1038/nn1491, PMID15965471 [dostęp 2022-08-29] (ang.).
  • J.M. Murray, Control of cell shape by calcium in the euglenophyceae, „Journal of Cell Science”, 49, 1981, s. 99–117, DOI10.1242/jcs.49.1.99, PMID6458623 [dostęp 2022-08-29].
  • Michael J. Glade, Caffeine-Not just a stimulant, „Nutrition (Burbank, Los Angeles County, Calif.)”, 26 (10), 2010, s. 932–938, DOI10.1016/j.nut.2010.08.004, PMID20888549 [dostęp 2022-08-29] (ang.).
  • Christian T. Wentz, Sanjay S.P. Magavi, Caffeine alters proliferation of neuronal precursors in the adult hippocampus, „Neuropharmacology”, 56 (6-7), 2009, s. 994–1000, DOI10.1016/j.neuropharm.2009.02.002, PMID19217915, PMCIDPMC2743873 [dostęp 2022-08-29] (ang.).
  • Myoung-Eun Han i inni, Inhibitory effects of caffeine on hippocampal neurogenesis and function, „Biochemical and Biophysical Research Communications”, 356 (4), 2007, s. 976–980, DOI10.1016/j.bbrc.2007.03.086, PMID17400186 [dostęp 2022-08-29] (ang.).
  • Daniel Borota i inni, Post-study caffeine administration enhances memory consolidation in humans, „Nature Neuroscience”, 17 (2), 2014, s. 201–203, DOI10.1038/nn.3623, PMID24413697, PMCIDPMC5909971 [dostęp 2022-08-29] (ang.).
  • Catarina Santos i inni, Caffeine intake and dementia: systematic review and meta-analysis, „Journal of Alzheimer's disease: JAD”, 20 Suppl 1, 2010, S187–204, DOI10.3233/JAD-2010-091387, PMID20182026 [dostęp 2022-08-29] (ang.).
  • Neal D. Freedman i inni, Association of Coffee Drinking with Total and Cause-Specific Mortality, „The New England Journal of Medicine”, 366, 2012, s. 1891–1904, DOI10.1056/NEJMoa1112010, PMID22591295, PMCIDPMC3439152.
  • E.J. Gardner, C.H.S. Ruxton, A.R. Leeds, Black tea--helpful or harmful? A review of the evidence, „European Journal of Clinical Nutrition”, 61 (1), 2007, s. 3–18, DOI10.1038/sj.ejcn.1602489, PMID16855537 [dostęp 2022-08-29] (ang.).
  • Shalini Dixit i inni, Consumption of Caffeinated Products and Cardiac Ectopy, „Journal of the American Heart Association”, 5 (1), 2016, DOI10.1161/JAHA.115.002503, PMID26813889, PMCIDPMC4859368.
  • Edoardo Casiglia i inni, Caffeine intake reduces incident atrial fibrillation at a population level, „European Journal of Preventive Cardiology”, 2018, DOI10.1177/2047487318772945, PMID29692210.
  • M. Bruce i inni, Anxiogenic effects of caffeine in patients with anxiety disorders, „Archives of General Psychiatry”, 49 (11), 1992, s. 867–869, DOI10.1001/archpsyc.1992.01820110031004, PMID1444724 [dostęp 2022-08-29] (ang.).
  • S.K. Bhattacharya, K.S. Satyan, A. Chakrabarti, Anxiogenic action of caffeine: an experimental study in rats, „Journal of Psychopharmacology”, 11 (3), 1997, s. 219–224, DOI10.1177/026988119701100304, PMID9305413 [dostęp 2022-08-29] (ang.).
  • B.E. Garrett, R.R. Griffiths, Physical dependence increases the relative reinforcing effects of caffeine versus placebo, „Psychopharmacology”, 139 (3), 1998, s. 195–202, DOI10.1007/s002130050704, PMID9784073 [dostęp 2022-08-29] (ang.).
  • Hisatsugu Miyata i inni, Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine, „Annals of the New York Academy of Sciences”, 1139, 2008, s. 458–465, DOI10.1196/annals.1432.030, PMID18991893 [dostęp 2022-08-29] (ang.).
  • Stephen Ozsungur, Darren Brenner, Ahmed El-Sohemy, Fourteen well-described caffeine withdrawal symptoms factor into three clusters, „Psychopharmacology”, 201 (4), 2009, s. 541–548, DOI10.1007/s00213-008-1329-y, PMID18795265 [dostęp 2022-08-29] (ang.).
  • Eric C. Strain i inni, Caffeine Dependence Syndrome: Evidence From Case Histories and Experimental Evaluations, „Journal of the American Medical Association”, 272 (13), 1994, s. 1043, DOI10.1001/jama.1994.03520130081037, PMID8089887 [dostęp 2022-08-29] (ang.).
  • G.B. Kaplan i inni, Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans, „Journal of Clinical Pharmacology”, 37 (8), 1997, s. 693–703, DOI10.1002/j.1552-4604.1997.tb04356.x, PMID9378841 [dostęp 2022-08-29] (ang.).
  • K.N. Stern, L.D. Chait, C.E. Johanson, Reinforcing and subjective effects of caffeine in normal human volunteers, „Psychopharmacology”, 98 (1), 1989, s. 81–88, DOI10.1007/BF00442010, PMID2498963 [dostęp 2022-08-29] (ang.).
  • R.R. Griffiths, P.P. Woodson, Reinforcing effects of caffeine in humans, „The Journal of Pharmacology and Experimental Therapeutics”, 246 (1), 1988, s. 21–29, DOI10.1016/0091-3057(91)90448-B, PMID3392652 [dostęp 2022-08-29] (ang.).
  • Kevin J. Acheson, Caffeine and insulin sensitivity, „Metabolic Syndrome and Related Disorders”, 3 (1), 2005, s. 19–25, DOI10.1089/met.2005.3.19, PMID18370706 [dostęp 2022-08-29] (ang.).
  • Sergi Ferré, An update on the mechanisms of the psychostimulant effects of caffeine, „Journal of Neurochemistry”, 105 (4), 2008, s. 1067–1079, DOI10.1111/j.1471-4159.2007.05196.x, PMID18088379 [dostęp 2022-08-29] (ang.).
  • Gabriel Bioh, Mark M. Gallagher, Usha Prasad, Survival of a highly toxic dose of caffeine, „BMJ Case Reports”, 2013, 2013, DOI10.1136/bcr-2012-007454, ISSN 1757-790X, PMID23396922, PMCIDPMC3604494 [dostęp 2018-05-10].

erowid.org

europa.eu

echa.europa.eu

farmacjaija.pl

frostburg.edu

antoine.frostburg.edu

google.co.jp

books.google.co.jp

ico.org

  • Caffeine. International Coffee Organization. [dostęp 2009-08-01]. [zarchiwizowane z tego adresu (2009-03-27)].

jeremiahspick.com

mayoclinic.org

nhm.ac.uk

nih.gov

ncbi.nlm.nih.gov

  • PubChem: mateina. National Library of Medicine. [dostęp 2009-08-03]. Generally translated as mateine in articles written in English.
  • PubChem: guaranine. National Library of Medicine. [dostęp 2009-08-16].
  • D.S. Groisser, A study of caffeine in tea. I. A new spectrophotometric micro-method. II. Concentration of caffeine in various strengths, brands, blends, and types of teas, „The American Journal of Clinical Nutrition”, 31 (10), 1978, s. 1727–1731, DOI10.1093/ajcn/31.10.1727, PMID707326 [dostęp 2022-08-29] (ang.).
  • C.F. Haskell i inni, A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans, „Journal of Psychopharmacology”, 21 (1), 2007, s. 65–70, DOI10.1177/0269881106063815, PMID16533867 [dostęp 2022-08-29] (ang.).
  • Hendrik J. Smit, Elizabeth A. Gaffan, Peter J. Rogers, Methylxanthines are the psycho-pharmacologically active constituents of chocolate, „Psychopharmacology”, 176 (3-4), 2004, s. 412–419, DOI10.1007/s00213-004-1898-3, PMID15549276 [dostęp 2022-08-29] (ang.).
  • L.T. Benjamin, A.M. Rogers, A. Rosenbaum, Coca-Cola, caffeine, and mental deficiency: Harry Hollingworth and the Chattanooga trial of 1911, „Journal of the History of the Behavioral Sciences”, 27 (1), 1991, s. 42–55, DOI10.1002/1520-6696(199101)27:1<42::aid-jhbs2300270105>3.0.co;2-1, PMID2010614 [dostęp 2022-08-29] (ang.).
  • A. Nehlig, J.L. Daval, G. Debry, Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, „Brain Research. Brain Research Reviews”, 17 (2), 1992, s. 139–170, DOI10.1016/0165-0173(92)90012-b, PMID1356551 [dostęp 2022-08-29] (ang.).
  • A. Liguori, J.R. Hughes, J.A. Grass, Absorption and subjective effects of caffeine from coffee, cola and capsules, „Pharmacology, Biochemistry, and Behavior”, 58 (3), 1997, s. 721–726, DOI10.1016/s0091-3057(97)00003-8, PMID9329065 [dostęp 2022-08-29] (ang.).
  • R. Newton i inni, Plasma and salivary pharmacokinetics of caffeine in man, „European Journal of Clinical Pharmacology”, 21 (1), 1981, s. 45–52, DOI10.1007/BF00609587, PMID7333346 [dostęp 2022-08-29] (ang.).
  • J.R. Graham, Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine, „The New England Journal of Medicine”, 250 (22), 1954, s. 936–938, DOI10.1056/NEJM195406032502203, PMID13165929 [dostęp 2022-08-29] (ang.).
  • Herdis Bohn Olesen Brødbaek, Per Damkier, [The treatment of hyperemesis gravidarum with chlorobutanol-caffeine rectal suppositories in Denmark: practice and evidence], „Ugeskrift for Laeger”, 169 (22), 2007, s. 2122–2123, PMID17553397 [dostęp 2022-08-29] (duń.).
  • F.P. Meyer i inni, [Time course of inhibition of caffeine elimination in response to the oral depot contraceptive agent Deposiston. Hormonal contraceptives and caffeine elimination], „Zentralblatt Fur Gynakologie”, 113 (6), 1991, s. 297–302, PMID2058339 [dostęp 2022-08-29] (niem.).
  • W. Ortweiler i inni, [Determination of caffeine and metamizole elimination in pregnancy and after delivery as an in vivo method for characterization of various cytochrome p-450 dependent biotransformation reactions], „Biomedica Biochimica Acta”, 44 (7-8), 1985, s. 1189–1199, PMID4084271 [dostęp 2022-08-29] (niem.).
  • G. Fisone, A. Borgkvist, A. Usiello, Caffeine as a psychomotor stimulant: mechanism of action, „Cellular and molecular life sciences: CMLS”, 61 (7-8), 2004, s. 857–872, DOI10.1007/s00018-003-3269-3, PMID15095008 [dostęp 2022-08-29] (ang.).
  • S. Latini, F. Pedata, Adenosine in the central nervous system: release mechanisms and extracellular concentrations, „Journal of Neurochemistry”, 79 (3), 2001, s. 463–484, DOI10.1046/j.1471-4159.2001.00607.x, PMID11701750 [dostęp 2022-08-29] (ang.).
  • Radhika Basheer i inni, Adenosine and sleep-wake regulation, „Progress in Neurobiology”, 73 (6), 2004, s. 379–396, DOI10.1016/j.pneurobio.2004.06.004, PMID15313333 [dostęp 2022-08-29] (ang.).
  • Zhi-Li Huang i inni, Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine, „Nature Neuroscience”, 8 (7), 2005, s. 858–859, DOI10.1038/nn1491, PMID15965471 [dostęp 2022-08-29] (ang.).
  • J.M. Murray, Control of cell shape by calcium in the euglenophyceae, „Journal of Cell Science”, 49, 1981, s. 99–117, DOI10.1242/jcs.49.1.99, PMID6458623 [dostęp 2022-08-29].
  • Michael J. Glade, Caffeine-Not just a stimulant, „Nutrition (Burbank, Los Angeles County, Calif.)”, 26 (10), 2010, s. 932–938, DOI10.1016/j.nut.2010.08.004, PMID20888549 [dostęp 2022-08-29] (ang.).
  • Christian T. Wentz, Sanjay S.P. Magavi, Caffeine alters proliferation of neuronal precursors in the adult hippocampus, „Neuropharmacology”, 56 (6-7), 2009, s. 994–1000, DOI10.1016/j.neuropharm.2009.02.002, PMID19217915, PMCIDPMC2743873 [dostęp 2022-08-29] (ang.).
  • Myoung-Eun Han i inni, Inhibitory effects of caffeine on hippocampal neurogenesis and function, „Biochemical and Biophysical Research Communications”, 356 (4), 2007, s. 976–980, DOI10.1016/j.bbrc.2007.03.086, PMID17400186 [dostęp 2022-08-29] (ang.).
  • Daniel Borota i inni, Post-study caffeine administration enhances memory consolidation in humans, „Nature Neuroscience”, 17 (2), 2014, s. 201–203, DOI10.1038/nn.3623, PMID24413697, PMCIDPMC5909971 [dostęp 2022-08-29] (ang.).
  • Catarina Santos i inni, Caffeine intake and dementia: systematic review and meta-analysis, „Journal of Alzheimer's disease: JAD”, 20 Suppl 1, 2010, S187–204, DOI10.3233/JAD-2010-091387, PMID20182026 [dostęp 2022-08-29] (ang.).
  • Neal D. Freedman i inni, Association of Coffee Drinking with Total and Cause-Specific Mortality, „The New England Journal of Medicine”, 366, 2012, s. 1891–1904, DOI10.1056/NEJMoa1112010, PMID22591295, PMCIDPMC3439152.
  • E.J. Gardner, C.H.S. Ruxton, A.R. Leeds, Black tea--helpful or harmful? A review of the evidence, „European Journal of Clinical Nutrition”, 61 (1), 2007, s. 3–18, DOI10.1038/sj.ejcn.1602489, PMID16855537 [dostęp 2022-08-29] (ang.).
  • Shalini Dixit i inni, Consumption of Caffeinated Products and Cardiac Ectopy, „Journal of the American Heart Association”, 5 (1), 2016, DOI10.1161/JAHA.115.002503, PMID26813889, PMCIDPMC4859368.
  • Edoardo Casiglia i inni, Caffeine intake reduces incident atrial fibrillation at a population level, „European Journal of Preventive Cardiology”, 2018, DOI10.1177/2047487318772945, PMID29692210.
  • M. Bruce i inni, Anxiogenic effects of caffeine in patients with anxiety disorders, „Archives of General Psychiatry”, 49 (11), 1992, s. 867–869, DOI10.1001/archpsyc.1992.01820110031004, PMID1444724 [dostęp 2022-08-29] (ang.).
  • S.K. Bhattacharya, K.S. Satyan, A. Chakrabarti, Anxiogenic action of caffeine: an experimental study in rats, „Journal of Psychopharmacology”, 11 (3), 1997, s. 219–224, DOI10.1177/026988119701100304, PMID9305413 [dostęp 2022-08-29] (ang.).
  • B.E. Garrett, R.R. Griffiths, Physical dependence increases the relative reinforcing effects of caffeine versus placebo, „Psychopharmacology”, 139 (3), 1998, s. 195–202, DOI10.1007/s002130050704, PMID9784073 [dostęp 2022-08-29] (ang.).
  • Hisatsugu Miyata i inni, Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine, „Annals of the New York Academy of Sciences”, 1139, 2008, s. 458–465, DOI10.1196/annals.1432.030, PMID18991893 [dostęp 2022-08-29] (ang.).
  • Stephen Ozsungur, Darren Brenner, Ahmed El-Sohemy, Fourteen well-described caffeine withdrawal symptoms factor into three clusters, „Psychopharmacology”, 201 (4), 2009, s. 541–548, DOI10.1007/s00213-008-1329-y, PMID18795265 [dostęp 2022-08-29] (ang.).
  • Eric C. Strain i inni, Caffeine Dependence Syndrome: Evidence From Case Histories and Experimental Evaluations, „Journal of the American Medical Association”, 272 (13), 1994, s. 1043, DOI10.1001/jama.1994.03520130081037, PMID8089887 [dostęp 2022-08-29] (ang.).
  • G.B. Kaplan i inni, Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans, „Journal of Clinical Pharmacology”, 37 (8), 1997, s. 693–703, DOI10.1002/j.1552-4604.1997.tb04356.x, PMID9378841 [dostęp 2022-08-29] (ang.).
  • K.N. Stern, L.D. Chait, C.E. Johanson, Reinforcing and subjective effects of caffeine in normal human volunteers, „Psychopharmacology”, 98 (1), 1989, s. 81–88, DOI10.1007/BF00442010, PMID2498963 [dostęp 2022-08-29] (ang.).
  • R.R. Griffiths, P.P. Woodson, Reinforcing effects of caffeine in humans, „The Journal of Pharmacology and Experimental Therapeutics”, 246 (1), 1988, s. 21–29, DOI10.1016/0091-3057(91)90448-B, PMID3392652 [dostęp 2022-08-29] (ang.).
  • Kevin J. Acheson, Caffeine and insulin sensitivity, „Metabolic Syndrome and Related Disorders”, 3 (1), 2005, s. 19–25, DOI10.1089/met.2005.3.19, PMID18370706 [dostęp 2022-08-29] (ang.).
  • Sergi Ferré, An update on the mechanisms of the psychostimulant effects of caffeine, „Journal of Neurochemistry”, 105 (4), 2008, s. 1067–1079, DOI10.1111/j.1471-4159.2007.05196.x, PMID18088379 [dostęp 2022-08-29] (ang.).
  • Gabriel Bioh, Mark M. Gallagher, Usha Prasad, Survival of a highly toxic dose of caffeine, „BMJ Case Reports”, 2013, 2013, DOI10.1136/bcr-2012-007454, ISSN 1757-790X, PMID23396922, PMCIDPMC3604494 [dostęp 2018-05-10].

pubchem.ncbi.nlm.nih.gov

digestive.niddk.nih.gov

  • Fecal Incontinence [online], National Digestive Diseases Information Clearinghouse [dostęp 2022-08-29] [zarchiwizowane z adresu 2010-07-22] (ang.).

nobelprize.org

nobleharbor.com

orthomolecular.org

pap.pl

naukawpolsce.pap.pl

redding.com

sigmaaldrich.com

thinkgeek.com

ugeskriftet.dk

umcs.pl

bc.umcs.pl

unam.mx

revistas.unam.mx

urpl.gov.pl

web.archive.org

worldcat.org